MedTrace Logo

Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and Telehealth

NCT04630015 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 134

Last updated 2023-05-09

No results posted yet for this study

Summary

This study evaluates the effects of the Survivorship Wellness Group Program following active treatment, as well as to learn from Survivorship Wellness participants about their concerns regarding the current COVID-19 pandemic. This study may help to evaluate the impact of the survivorship program on patient well-being, provide evidence for use in grant application and publications, and ultimately inform the continued improvement of survivorship care.

Conditions

  • COVID-19 Infection
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm

Interventions

OTHER

Survey Administration

Participants will complete study specific survey

Sponsors & Collaborators

Principal Investigators

  • Margaret Chesney, MD · University of California, San Francisco

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-31
Primary Completion
2023-05-01
Completion
2023-05-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04630015 on ClinicalTrials.gov